Bilcare
BI NSE
Bilcare
HealthcareNSE: BI BSE: 526853 Healthcare Technology
Key Fundamentals
MicrocapHealthcare TechnologyHealthcareMarket Cap
₹212 Cr
Volatility
Moderate
P/E Ratio
14.91
EBITDA
₹40.63 Cr
Return on Equity
-9.53%
Debt to Equity
3.15
Book Value
₹83.55
52W High
₹111.51
52W Low
₹51.62
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 1.11 times its book value
Weaknesses
5- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.33% over past five years.
- Promoter holding is low: 30.0%
- Company has a low return on equity of -4.07% over last 3 years.
- Contingent liabilities of Rs.727 Cr.
Growth Rate
Revenue Growth
-9.05% lower than
3Y
Net Income Growth
-61.9% lower than
3Y
Cash Flow Change
995% higher than
3Y
ROE
5.19% higher than
3Y
ROCE
24.1% higher than
3Y
EBITDA Margin (Avg.)
-31.97% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 182 | 190 | 175 | 200 | 194 | 202 | 198 | 194 | 186 | 178 | 181 | 188 | 226 |
| Expenses | 169 | 173 | 158 | 208 | 175 | 194 | 187 | 186 | 175 | 175 | 168 | 171 | 189 |
| Operating Profit | 13 | 17 | 17 | -8 | 19 | 8 | 11 | 8 | 11 | 3 | 13 | 17 | 37 |
| OPM % | 7% | 9% | 10% | -4.1% | 10% | 3.8% | 5% | 4% | 6% | 1.9% | 7% | 9% | 16% |
| Other Income | 3 | 1 | 4 | 9 | 4 | -6 | -6 | 21 | 6 | 4 | 3 | 12 | 0 |
| Interest | 19 | 20 | 21 | 23 | 21 | 24 | 19 | 19 | 19 | 19 | 17 | 18 | 18 |
| Depreciation | 10 | 10 | 11 | 13 | 12 | 11 | 12 | 5 | 12 | 12 | 5 | 5 | 4 |
| PBT | -13 | -13 | -10 | -35 | -10 | -33 | -27 | 6 | -13 | -24 | -6 | 7 | 15 |
| Tax % | -1% | -5% | 34% | -44% | 55% | -10% | -40% | -119% | -25% | -1% | 3% | -13% | -1% |
| Net Profit | -13 | -12 | -14 | -20 | -15 | -30 | -16 | 12 | -10 | -23 | -6 | 8 | 15 |
| EPS in Rs | -3.36 | -3.22 | -2.91 | -4.63 | -2.71 | -6.81 | -3.04 | 7.47 | -1.61 | -5.25 | 0.41 | 5.68 | 5.39 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,692 | 2,603 | 2,633 | 2,778 | 2,997 | 1,827 | 623 | 845 | 982 | 747 | 788 | 734 | 773 |
| Expenses | 2,506 | 2,396 | 2,443 | 2,617 | 2,827 | 1,782 | 572 | 784 | 925 | 708 | 743 | 689 | 703 |
| Operating Profit | 186 | 207 | 190 | 161 | 170 | 45 | 51 | 60 | 57 | 39 | 45 | 44 | 70 |
| OPM % | 7% | 8% | 7% | 6% | 6% | 2.5% | 8% | 7% | 6% | 5% | 6% | 6% | 9% |
| Other Income | 9 | -87 | 107 | 297 | 59 | 254 | 45 | 44 | 237 | 16 | 12 | 26 | 20 |
| Interest | 236 | 151 | 176 | 249 | 283 | 174 | 76 | 69 | 60 | 82 | 82 | 72 | 72 |
| Depreciation | 191 | 164 | 177 | 416 | 378 | 239 | 46 | 39 | 38 | 45 | 46 | 20 | 26 |
| PBT | -232 | -194 | -56 | -207 | -433 | -114 | -25 | -4 | 196 | -72 | -71 | -21 | -7 |
| Tax % | -7% | -58% | 42% | -4% | 5% | -13% | -55% | 3% | 74% | -18% | -21% | -19% | — |
| Net Profit | -216 | -82 | -80 | -199 | -453 | -99 | -11 | -4 | 50 | -59 | -56 | -17 | -6 |
| EPS in Rs | -91.76 | -36.04 | -35.91 | -85.43 | -193 | -43.97 | -8.95 | -5.35 | 6.39 | -14.12 | -12.23 | 0.73 | 6.23 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 1,073 | 689 | 590 | 376 | -93 | 85 | 63 | 52 | 507 | 474 | 445 | 173 |
| Borrowings | 2,311 | 2,122 | 2,014 | 2,089 | 2,270 | 707 | 677 | 690 | 639 | 756 | 682 | 620 |
| Other Liabilities | 933 | 786 | 830 | 913 | 888 | 297 | 300 | 362 | 424 | 314 | 266 | 26 |
| Total Liabilities | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 | 843 |
| Fixed Assets | 1,926 | 2,432 | 2,403 | 2,180 | 2,005 | 534 | 494 | 465 | 1,045 | 1,038 | 949 | 433 |
| CWIP | 218 | 161 | 149 | 170 | 79 | 0 | 0 | 1 | 1 | 1 | 4 | 8 |
| Investments | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 8 | 11 | 14 |
| Other Assets | 2,196 | 1,026 | 904 | 1,051 | 1,003 | 577 | 570 | 661 | 545 | 521 | 453 | 387 |
| Total Assets | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 | 843 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -315 | 177 | 300 | 98 | 206 | 256 | 72 | 41 | -7 | 62 | 85 | 128 |
| Investing | 247 | -358 | -129 | -203 | -104 | 1,309 | 2 | -4 | 36 | -106 | 81 | -6 |
| Financing | 119 | 149 | -155 | 91 | -103 | -1,600 | -83 | -55 | -19 | 36 | -169 | -132 |
| Net Cash Flow | 50 | -32 | 16 | -13 | -1 | -35 | -9 | -18 | 10 | -7 | -3 | -10 |
| Free Cash Flow | -74 | -12 | 165 | -115 | 91 | 1,569 | 69 | 37 | 11 | -34 | 140 | 120 |
| CFO/OP | -170 | 85 | 173 | 75 | 148 | 828 | 141 | 78 | -6 | 162 | 193 | 284 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 125 | 35 | 29 | 38 | 38 | 22 | 90 | 95 | 70 | 73 | 55 | 54 |
| Inventory Days | 105 | 108 | 84 | 90 | 82 | 28 | 90 | 83 | 42 | 77 | 80 | 86 |
| Days Payable | 93 | 86 | 81 | 102 | 71 | 35 | 93 | 102 | 77 | 70 | 57 | 70 |
| Cash Conversion Cycle | 137 | 57 | 32 | 25 | 49 | 15 | 88 | 76 | 34 | 80 | 78 | 69 |
| Working Capital Days | 125 | 5 | -11 | -150 | -156 | -2 | -19 | -10 | -10 | 12 | -5 | 28 |
| ROCE % | 1% | 2% | 2% | -8% | -6% | -9% | 3% | 3% | 3% | 1% | 1% | 6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Bilcare insights
50 extracted metrics + investor summaries across FY15–FY26.
Documents
1
Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/ CIR/2023/172 Dated October 19, 2023
29 Apr - Bilcare confirms it is not a Large Corporate under SEBI debt fundraising circular. 29 Apr - Bilcare confirms it is not a Large Corporate under SEBI debt fundraising circular.
2
Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/ CIR/2023/172 Dated October 19, 2023
29 Apr - Bilcare confirms it is not a Large Corporate under SEBI debt fundraising circular. 29 Apr - Bilcare confirms it is not a Large Corporate under SEBI debt fundraising circular.
3
Announcement under Regulation 30 (LODR)-Cessation
25 Apr - Madhuri Vaidya’s term ends 26 Apr 2026; Ashwini Hasabnis appointed independent director, committees reconstituted. 25 Apr - Madhuri Vaidya’s term ends 26 Apr 2026; Ashwini Hasabnis appointed independent director, committees reconstituted.
4
Announcement under Regulation 30 (LODR)-Cessation
25 Apr - Madhuri Vaidya’s term ends 26 Apr 2026; Ashwini Hasabnis appointed independent director, committees reconstituted. 25 Apr - Madhuri Vaidya’s term ends 26 Apr 2026; Ashwini Hasabnis appointed independent director, committees reconstituted.
5
Announcement under Regulation 30 (LODR)-Change in Directorate
25 Apr - Adv. Ashwini Hasabnis appointed additional independent director from 25 Apr 2026; committees reconstituted. 25 Apr - Adv. Ashwini Hasabnis appointed additional independent director from 25 Apr 2026; committees reconstituted.
Frequently Asked Questions about Bilcare
What does Bilcare Ltd do?
Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).
Where is Bilcare Ltd (526853) listed?
Bilcare Ltd trades as BI on the NSE and under code 526853 on the BSE.
Which sector does Bilcare Ltd belong to?
Bilcare Ltd is classified under the Healthcare sector, in the Healthcare Technology industry.
What is the market capitalisation of Bilcare Ltd?
Bilcare Ltd has a market capitalisation of ₹211.91 Cr, which places it in the Small Cap band.
What is the PE ratio of Bilcare Ltd?
Bilcare Ltd trades at a PE ratio of 14.91, against a book value of ₹83.55 per share.
What is the 52-week high and low of Bilcare Ltd?
Over the last 52 weeks Bilcare Ltd has traded between ₹51.62 and ₹111.51.
What is the Return on Equity (ROE) of Bilcare Ltd?
Bilcare Ltd reported a return on equity of -9.53%. Its debt-to-equity ratio is 3.15.
Company Information
Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526853.md for Bilcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.